GL Pharm Tech Corp. (KOSDAQ:204840)
South Korea
· Delayed Price · Currency is KRW
1,057.00
-8.00 (-0.75%)
At close: Apr 29, 2026
GL Pharm Tech Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 81,969 | 84,606 | 75,097 | 70,834 | 46,578 | 76,699 | |
| Market Cap Growth | 4.52% | 12.66% | 6.02% | 52.08% | -39.27% | 12.04% | |
| Enterprise Value | 97,666 | 99,657 | 82,885 | 82,845 | 55,794 | 82,225 | |
| Last Close Price | 1057.00 | 1091.00 | 977.00 | 1136.00 | 750.00 | 1240.00 | |
| PE Ratio | 6563.33 | 6774.45 | - | - | - | - | |
| PS Ratio | 2.32 | 2.40 | 2.88 | 2.72 | 2.78 | 6.17 | |
| PB Ratio | 4.12 | 4.25 | 3.82 | 5.77 | 2.90 | 4.39 | |
| P/TBV Ratio | 4.23 | 4.36 | 3.98 | 6.18 | 3.10 | 4.92 | |
| EV/Sales Ratio | 2.77 | 2.83 | 3.18 | 3.18 | 3.34 | 6.62 | |
| EV/EBITDA Ratio | 63.03 | 78.44 | - | - | - | - | |
| EV/EBIT Ratio | 178.36 | 371.20 | - | - | - | - | |
| Debt / Equity Ratio | 0.94 | 0.94 | 0.75 | 1.45 | 0.86 | 0.45 | |
| Debt / EBITDA Ratio | 14.75 | 14.75 | - | - | - | - | |
| Net Debt / Equity Ratio | 0.79 | 0.79 | 0.53 | 1.11 | 0.58 | 0.10 | |
| Net Debt / EBITDA Ratio | 12.36 | 12.36 | -180.25 | -12.52 | -8.35 | -2.53 | |
| Net Debt / FCF Ratio | -3.63 | -3.63 | -2.06 | -3.15 | -1.20 | -0.47 | |
| Asset Turnover | 0.77 | 0.77 | 0.63 | 0.65 | 0.46 | 0.37 | |
| Inventory Turnover | 2.15 | 2.15 | 2.08 | 2.86 | 2.67 | 2.83 | |
| Quick Ratio | 0.48 | 0.48 | 0.74 | 0.81 | 0.79 | 2.02 | |
| Current Ratio | 1.01 | 1.01 | 1.37 | 1.35 | 1.24 | 2.73 | |
| Return on Equity (ROE) | 0.06% | 0.06% | -14.63% | -26.42% | -4.71% | -23.49% | |
| Return on Assets (ROA) | 0.37% | 0.37% | -2.69% | -5.00% | -5.59% | -5.06% | |
| Return on Invested Capital (ROIC) | 0.13% | 0.13% | -6.31% | -12.59% | -14.62% | -14.63% | |
| Return on Capital Employed (ROCE) | 1.00% | 1.00% | -6.20% | -11.70% | -11.70% | -10.00% | |
| Earnings Yield | 0.02% | 0.01% | -3.11% | -5.29% | -1.70% | -4.86% | |
| FCF Yield | -5.28% | -5.11% | -6.71% | -6.13% | -16.55% | -4.69% | |
| Buyback Yield / Dilution | - | - | -21.16% | -0.34% | -21.96% | -13.03% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.